Fundraising Fox
Michael Anstey
InvestorPartner at Start Codon · Managing Partner at Cambridge Innovation Capital
Cambridge, United Kingdom
Writes $600K – $6M checks · typically $3.3M
Find your path to Michael
Sign up to see every warm intro you have to Michael
- Paths you didn't know you had: your email and LinkedIn already hold routes to Michael. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Michael Anstey pairs a DPhil in Zoology with co-founding an early-stage biotech targeting protein–protein interactions, backed Bicycle Therapeutics and Nuclera, and co-founded Innovate Cambridge to boost Greater Cambridge's innovation ecosystem.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechDeep TechHardwareHealthtechSemiconductors
Investments
Investor
ImmutrinPredictImmuneTRIMTech Therapeutics
Per curated public sources.
Colleagues at Start Codon
Network4
Investors connected to Michael in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Michael Anstey?
- Michael Anstey pairs a DPhil in Zoology with co-founding an early-stage biotech targeting protein–protein interactions, backed Bicycle Therapeutics and Nuclera, and co-founded Innovate Cambridge to boost Greater Cambridge's innovation ecosystem.
- Where does Michael Anstey work?
- Michael Anstey is Partner at Start Codon and Managing Partner at Cambridge Innovation Capital.
- What does Michael Anstey invest in?
- Michael Anstey invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Semiconductors.
- What check size does Michael Anstey write?
- Michael Anstey typically writes checks of $600K – $6M.
- What companies has Michael Anstey invested in?
- Investments tracked here include Immutrin, PredictImmune, TRIMTech Therapeutics.
About this profile. Compiled from public sources — Start Codon's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights